DE602006016106D1 - Zusammensetzungen und verfahren zur vorhersage des ausgangs einer behandlung - Google Patents
Zusammensetzungen und verfahren zur vorhersage des ausgangs einer behandlungInfo
- Publication number
- DE602006016106D1 DE602006016106D1 DE602006016106T DE602006016106T DE602006016106D1 DE 602006016106 D1 DE602006016106 D1 DE 602006016106D1 DE 602006016106 T DE602006016106 T DE 602006016106T DE 602006016106 T DE602006016106 T DE 602006016106T DE 602006016106 D1 DE602006016106 D1 DE 602006016106D1
- Authority
- DE
- Germany
- Prior art keywords
- compositions
- markers
- treatment
- predicting
- output
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G01N33/57557—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Processing Of Solid Wastes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68607005P | 2005-05-31 | 2005-05-31 | |
| PCT/DK2006/000300 WO2006128463A2 (en) | 2005-05-31 | 2006-05-30 | Compositions and methods for predicting outcome of treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006016106D1 true DE602006016106D1 (de) | 2010-09-23 |
Family
ID=35809661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006016106T Active DE602006016106D1 (de) | 2005-05-31 | 2006-05-30 | Zusammensetzungen und verfahren zur vorhersage des ausgangs einer behandlung |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8679746B2 (de) |
| EP (1) | EP1885878B1 (de) |
| AT (1) | ATE477339T1 (de) |
| DE (1) | DE602006016106D1 (de) |
| ES (1) | ES2350648T3 (de) |
| WO (1) | WO2006128463A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009154669A1 (en) * | 2008-05-28 | 2009-12-23 | Albert Einstein College Of Medicine Of Yeshiva University | Prediction of chemotherapeutic response via single-cell profiling of transcription site activation |
| EP3216874A1 (de) | 2008-09-05 | 2017-09-13 | TOMA Biosciences, Inc. | Verfahren zum stratifizieren und annotieren der behandlungsoptionen eines krebsmedikaments |
| EP2446053A1 (de) * | 2009-05-29 | 2012-05-02 | Ventana Medical Systems, Inc. | Verfahren zur zählung der genkopiezahl in einer biologischen probe mittels in-situ-hybrdisierung |
| US9309556B2 (en) | 2010-09-24 | 2016-04-12 | The Board Of Trustees Of The Leland Stanford Junior University | Direct capture, amplification and sequencing of target DNA using immobilized primers |
| US9556473B2 (en) * | 2011-02-15 | 2017-01-31 | Leica Biosystems Newcastle Ltd | Methods for identifying nucleic acid sequences |
| CN106338423B (zh) | 2015-07-10 | 2020-07-14 | 三斯坎公司 | 组织学染色的空间复用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004004571T2 (de) | 2003-08-28 | 2007-11-08 | Roche Diagnostics Gmbh | Abhängigkeit des symptomfreien Überlebens 5-FU behandelter Darmkrebspatienten vom Verhältnis der mRNA-Expressionshöhe aus Thymidinphosphorylase und Dihydropyrimidindehydrogenase |
-
2006
- 2006-05-30 DE DE602006016106T patent/DE602006016106D1/de active Active
- 2006-05-30 US US11/915,970 patent/US8679746B2/en active Active
- 2006-05-30 AT AT06742440T patent/ATE477339T1/de not_active IP Right Cessation
- 2006-05-30 ES ES06742440T patent/ES2350648T3/es active Active
- 2006-05-30 EP EP06742440A patent/EP1885878B1/de not_active Not-in-force
- 2006-05-30 WO PCT/DK2006/000300 patent/WO2006128463A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US8679746B2 (en) | 2014-03-25 |
| EP1885878A2 (de) | 2008-02-13 |
| US20090042187A1 (en) | 2009-02-12 |
| WO2006128463A2 (en) | 2006-12-07 |
| EP1885878B1 (de) | 2010-08-11 |
| WO2006128463A3 (en) | 2007-02-15 |
| ES2350648T3 (es) | 2011-01-25 |
| ATE477339T1 (de) | 2010-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE464323T1 (de) | Zusammensetzungen und verfahren für die tumor- diagnose und behandlung | |
| EP1945754A4 (de) | Zusammensetzungen und verfahren zur behandlung und diagnostizierung von krebs | |
| ATE523525T1 (de) | Anti-tumorassoziiertes antigen tat10772 zum nachweis und behandlung von krebs | |
| EP1765391A4 (de) | Bakterielle zusammensetzungen zur behandlung von krebs | |
| EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
| CY1109741T1 (el) | Sns-595 και μεθοδοι χρησης αυτου | |
| IL258880A (en) | Diarylhydantoin compounds | |
| ATE497496T1 (de) | 2,4-pyridimediamon-derivate als hemmer von jak- kinasen zur behandlung von autoimmunerkrankungen | |
| EP2125855A4 (de) | Verfahren und zusammensetzungen zur behandlung von krebs und anderen krankheiten | |
| DE602005005810D1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| EA201001143A1 (ru) | Активаторы прокаспаз "исполнителей" 3, 6 и 7 | |
| DE602006018057D1 (de) | Substituierte chinolone und verwendungsverfahren | |
| BRPI0519424A2 (pt) | composiÇÕes e mÉtodos para tratamento de distérbios de proliferaÇço celular | |
| EP1663259A4 (de) | Zusammensetzungen und verfahren zur behandlung von krebs | |
| MX2009006466A (es) | Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina. | |
| EA200870391A1 (ru) | Тетрагидропирролопиримидиндионы и их применение в качестве ингибиторов эластазы нейтрофилов человека | |
| UA100007C2 (ru) | Гетероциклические ингибиторы мек, их применение и фармацевтическая композиция, которая их содержит | |
| ATE432924T1 (de) | 3-aminoindazole derivate und ihre verwendung zur behandlung sgk-bedingten krankheiten | |
| EP2141989A4 (de) | Zusammensetzungen und verfahren zur vorbeugung und behandlung von suchtkrankheiten | |
| ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| BRPI0514586A (pt) | triazolftalazinas | |
| TW200626900A (en) | Wnt proteins and detection and treatment of cancer | |
| WO2006113483A3 (en) | Methods and compositions for treating or preventing cancer | |
| TNSN06321A1 (en) | Beta-carbolines useful for treating inflammatory disease | |
| DE602006016106D1 (de) | Zusammensetzungen und verfahren zur vorhersage des ausgangs einer behandlung |